Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,807 | 49,326 | 60,599 | 17,379 | N/A |
| Receivables | 6,955 | 13,130 | 6,481 | 6,179 | N/A |
| Inventories | 2,461 | 2,859 | 5,441 | 4,014 | N/A |
| TOTAL | $44,625 | $68,314 | $74,201 | $28,163 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 6,873 | 9,726 | 12,207 | 13,460 | N/A |
| Intangibles | 102 | 153 | 443 | 254 | 0 |
| Other Non-Current Assets | 11,284 | 286 | 0 | 1,239 | 0 |
| TOTAL | $18,259 | $10,165 | $12,650 | $14,953 | $N/A |
| Total Assets | $62,884 | $78,479 | $86,851 | $43,116 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,664 | 12,274 | 25,036 | 9,601 | 0 |
| Accrued Expenses | 8,569 | 5,475 | 7,195 | 4,402 | N/A |
| Other current liabilities | 1,450 | N/A | N/A | N/A | N/A |
| TOTAL | $21,104 | $18,555 | $32,952 | $15,350 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,329 | 60,338 | 42,603 | 45,507 | N/A |
| Deferred Revenues | 693 | 806 | 721 | 1,347 | N/A |
| Other Non-Current Liabilities | 52,315 | 1,360 | 1,216 | 8,754 | 0 |
| TOTAL | $90,277 | $66,046 | $43,819 | $54,261 | $N/A |
| Total Liabilities | $111,381 | $84,601 | $76,771 | $69,611 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,214 | 33,582 | 24,975 | N/A | N/A |
| Common Shares | 35 | 34 | 25 | 12,727 | N/A |
| Retained earnings | -186,257 | -130,474 | -61,376 | -120,093 | N/A |
| Other shareholders' equity | 0 | 0 | 0 | 42,101 | 0 |
| TOTAL | $-48,497 | $-6,122 | $10,080 | $-26,495 | $N/A |
| Total Liabilities And Equity | $62,884 | $78,479 | $86,851 | $43,116 | $0 |